Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, and Volpara Health, a company that offers AI-powered software to help providers better understand cancer risk, announced they are joining forces to develop…
Continue Reading
Lunit collabs with AstraZeneca, secures major deal in France Lunit and AstraZeneca have partnered to develop new AI-powered digital pathology solutions that predict non-small cell lung cancer (NSCLC).
Based on a media release, their collaboration aims…
Advancing precision in lung cancer diagnostics: Lunit’s collaboration with AstraZeneca aims to transform the speed and accuracy of detecting actionable mutations in NSCLC. (Courtesy of Lunit)
What You Should Know:
– Lunit, a provider of AI…
Continue Reading
What You Should Know:
– Lunit, a leading provider of AI-powered cancer diagnostics solutions, has announced a strategic alliance with VIDI Group, the largest private radiology and radiotherapy network in France.
– The partnership will expand…
Continue Reading
Introduction
Artificial intelligence (AI) is transforming breast cancer detection by enhancing early diagnosis and alleviating radiologist workload, essential for improving patient outcomes and screening efficiency. A recent study, conducted by researchers from Norway and Denmark,…
Health systems that embrace artificial intelligence tools can not only improve radiology operations and quality but patient follow-up as well, which can result in greater staff efficiencies, higher patient completion rates and better access…
Continue Reading
New AI Technology Enhances Cancer Treatment: Introduction
In the field of cancer treatment, personalized medicine has become a crucial focus, with immunotherapy revolutionizing the treatment of many cancers. However, predicting which patients will respond positively…
The National Healthcare Group, the health cluster covering central and north Singapore, seeks to integrate an AI assistant into its radiology workflow.According to a media release, the group will be deploying South Korea-based Lunit’s…
Continue Reading
Introduction
Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, has made a significant move to bolster its leadership team by appointing Teri Thomas as Chief Business Officer (CBO) of its Cancer…
South Korean medical AI company Lunit has recently secured deals with hospitals in Europe, where the medical device market – the second largest after the North American market – is worth $155 billion.It won the contract to supply…
Continue Reading
